Ossiam Vertex Pharmaceuticals Inc Transaction History

Ossiam

$5.65 Billion
Q1 2024

A detailed history of Ossiam transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ossiam holds 11,094 shares of VRTX stock, worth $5.26 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

11,094

Previous 8,994 23.35%

Holding current value

$5.26 Million

Previous $3.66 Million 26.73%

% of portfolio

0.08%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $856,149 - $936,768	2,100 Added 23.35%	11,094 $4.64 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $424,634 - $508,421	1,238 Added 15.96%	8,994 $3.66 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $76,766 - $82,278	227 Added 3.02%	7,756 $2.7 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $28.8 Million - $32.2 Million	-91,574 Reduced 92.4%	7,529 $2.65 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $862,152 - $983,516	3,044 Added 3.17%	99,103 $31.2 Million

Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $504,366 - $567,412	1,765 Added 1.87%	96,059 $27.7 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $483,036 - $538,954	-1,764 Reduced 1.84%	94,294 $27.3 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $466,160 - $580,419	1,984 Added 2.11%	96,058 $27.1 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $890,108 - $1.05 Million	4,020 Added 4.46%	94,074 $24.6 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $15.5 Million - $19.5 Million	87,369 Added 3253.97%	90,054 $19.8 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $71,286 - $79,775	393 Added 17.15%	2,685 $487,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $501,723 - $591,663	-2,676 Reduced 53.86%	2,292 $462,000
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $975,271 - $1.14 Million	4,711 Added 1833.07%	4,968 $1.07 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $42,437 - $56,598	205 Added 394.23%	257 $61,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $511 - $606	-2 Reduced 3.7%	52 $14,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $756,936 - $993,000	-3,357 Reduced 98.42%	54 $16,000
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $570,942 - $708,240	2,858 Added 516.82%	3,411 $812,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $57,848 - $77,696	-347 Reduced 38.56%	553 $121,000
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $98,075 - $110,383	590 Added 190.32%	900 $152,000
Q2 2019 Aug 13, 2019	SELL	$164.61 - $190.37 $2.88 Million - $3.33 Million	-17,472 Reduced 98.26%	310 $57,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $1.57 Million - $1.86 Million	-9,563 Reduced 34.97%	17,782 $3.27 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $4.15 Million - $5.26 Million	27,345 New	27,345 $4.53 Million

Others Institutions Holding VRTX

# of Institutions

1,624

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account